您要查找的是不是：
- comary restenosis 冠状动脉再狭窄
- Restenosis was demonstrated in 2 patients. 2例发生再狭窄；
- Restenosis (RS) is the Achilles heel of PTCA and PCI. 近年来，有研究者尝试在PTCA后辅以低强度激光冠脉内照射防治RS，取得一定效果，但许多问题尚待解决。
- DESs' TLR and Restenosis Late Catch Up: Is it Hold True? 药物洗脱支架存在TLR和再狭窄后期赶上现象吗？
- It's a new research of prevention and treatment restenosis with BPD-MA-PDT. 将BPD-MA-PDT应用到RS的防治是一个新的课题。
- At home and abroad to restenosis the prevention and treatment research is hot. 国内外对再狭窄的预防及治疗是研究热点。
- The recurrence of symptoms several years after an excellent clinical and hemodynamic result may be due to restenosis of the mitral value. 临床上和血液动力学上取得极好结果，如果过几年后症状复现，可能由二尖瓣重新狭窄所引起。
- Puzzle or Hope? Are Endothelial Progenitor Cell Capture Stents the Next Potential Treatment for Restenosis? 内皮祖细胞捕获支架的困惑与希望?
- The restenosis in the end-to end anastomosis existed in 2 cases by ECHO with 29 mm Hg and 36 mm Hg, respectively. 超声检查示2例有残余主动脉缩窄;压力阶差分别为29和36min Hg(1 mm Hg=0.;133 kPa)。
- After 6-12 months,the restenosis rate in the FBS group is less than that in the PES group(5.3% vs 21.9%,P<0.001). 6个月后随访结果国产西罗莫司洗脱支架组的支架再狭窄率明显低于紫杉醇洗脱支架组(5.;3%25比21
- To observe the efficacy and safety of intracoronary brachytherapy(ICBT) on patients with in-stent restenosis(ISR). 观察冠脉内放射治疗(ICBT)支架内再狭窄(ISR)的临床疗效及安全性。
- Some new therapies to prevent restenosis after percutaneous coronary intervention were discussed in the article. 本文探讨和评价一些预防和治疗冠状动脉内介入治疗后再狭窄的新的措施或思路。
- In 1 patient,deformation of stent was not found by CT,but in stent restenosis was found by CAG and IVUS examination. 1例患者CT检查并未发现支架变形，但冠状动脉造影和IVUS检查发现支架内再狭窄；
- Objective To construct the SD rat model of saphenous vein grafts restenosis after coronary artery bypass grafting. 目的建立一种与冠脉旁路移植术后静脉桥再狭窄病理过程相似的动物模型。
- Thirdly, is the restenosis rate high if stent is implanted into CMB mural artery? 第三，对心肌桥血管行支架置入再狭窄发生率是否偏高。
- Result There was no bronchopleural fistula、 tracheobronchial restenosis and death due to operation. 结果术后效果良好，无支气管胸膜瘘、气管再狭窄和手术死亡。
- Probucol has been shown to prevent coronary restenosis after balloon angioplasty in clinical trials. 许多临床试验证实普罗布考能够预防管腔成形术后的冠脉再狭窄。
- Restenosis is a major problem in the field of percutaneous coronary intervention. 再狭窄是经皮冠状动脉介入治疗领域的难题。
- The diffuse restenosis lesion were common in taxus stent than that in other DES. 紫杉醇药物释放支架弥漫性再狭窄发生率较雷帕霉素释放支架有所增加。
- Conclusion: Diabetes may be a powerful predicating factor for restenosis after intracoronary stenting. 结论：糖尿病可作为冠脉内支架植入术后再狭窄的强预测因子。
